-
Comparison of neuromuscular fatigue in chronic stroke patients with healthy controls
Shweta Kotwani, Sharmishtha Gadgil and Parag Ranade
Research Article: Clinical Investigation
-
Comparison of neuromuscular fatigue in chronic stroke patients with healthy controls
Shweta Kotwani, Sharmishtha Gadgil and Parag Ranade
Research Article: Clinical Investigation
-
Comparison of neuromuscular fatigue in chronic stroke patients with healthy controls
Shweta Kotwani, Sharmishtha Gadgil and Parag Ranade
Research Article: Clinical Investigation
-
Comparison of neuromuscular fatigue in chronic stroke patients with healthy controls
Shweta Kotwani, Sharmishtha Gadgil and Parag Ranade
Research Article: Clinical Investigation
-
Comparison of neuromuscular fatigue in chronic stroke patients with healthy controls
Shweta Kotwani, Sharmishtha Gadgil and Parag Ranade
Research Article: Clinical Investigation
-
Comparison of neuromuscular fatigue in chronic stroke patients with healthy controls
Shweta Kotwani, Sharmishtha Gadgil and Parag Ranade
Research Article: Clinical Investigation
-
Comparison of neuromuscular fatigue in chronic stroke patients with healthy controls
Shweta Kotwani, Sharmishtha Gadgil and Parag Ranade
Research Article: Clinical Investigation
-
Comparison of neuromuscular fatigue in chronic stroke patients with healthy controls
Shweta Kotwani, Sharmishtha Gadgil and Parag Ranade
Research Article: Clinical Investigation
-
Corrigendum: Clinical Investigation 2014 4:9, 847-865.
Corrigendum: Clinical Investigation
-
Corrigendum: Clinical Investigation 2014 4:9, 847-865.
Corrigendum: Clinical Investigation
-
Corrigendum: Clinical Investigation 2014 4:9, 847-865.
Corrigendum: Clinical Investigation
-
Corrigendum: Clinical Investigation 2014 4:9, 847-865.
Corrigendum: Clinical Investigation
-
Corrigendum: Clinical Investigation 2014 4:9, 847-865.
Corrigendum: Clinical Investigation
-
Corrigendum: Clinical Investigation 2014 4:9, 847-865.
Corrigendum: Clinical Investigation
-
Corrigendum: Clinical Investigation 2014 4:9, 847-865.
Corrigendum: Clinical Investigation
-
Corrigendum: Clinical Investigation 2014 4:9, 847-865.
Corrigendum: Clinical Investigation
-
What is the potential of Rho kinase inhibitors in the treatment of glaucoma?
Sarah Van de Velde
Editorial: Clinical Investigation
-
What is the potential of Rho kinase inhibitors in the treatment of glaucoma?
Sarah Van de Velde
Editorial: Clinical Investigation
-
What is the potential of Rho kinase inhibitors in the treatment of glaucoma?
Sarah Van de Velde
Editorial: Clinical Investigation
-
What is the potential of Rho kinase inhibitors in the treatment of glaucoma?
Sarah Van de Velde
Editorial: Clinical Investigation
-
What is the potential of Rho kinase inhibitors in the treatment of glaucoma?
Sarah Van de Velde
Editorial: Clinical Investigation
-
What is the potential of Rho kinase inhibitors in the treatment of glaucoma?
Sarah Van de Velde
Editorial: Clinical Investigation
-
What is the potential of Rho kinase inhibitors in the treatment of glaucoma?
Sarah Van de Velde
Editorial: Clinical Investigation
-
What is the potential of Rho kinase inhibitors in the treatment of glaucoma?
Sarah Van de Velde
Editorial: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 5
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 5
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 5
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 5
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 5
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 5
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 5
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 5
Acknowledgements: Clinical Investigation
-
Emerging medical treatments for actinic keratoses, squamous cell carcinoma and basal cell carcinoma
Nasreen Ghuznavi, Nadia F Nocera, Andrew R Guajardo, Jeffrey M Weinberg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Emerging medical treatments for actinic keratoses, squamous cell carcinoma and basal cell carcinoma
Nasreen Ghuznavi, Nadia F Nocera, Andrew R Guajardo, Jeffrey M Weinberg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Emerging medical treatments for actinic keratoses, squamous cell carcinoma and basal cell carcinoma
Nasreen Ghuznavi, Nadia F Nocera, Andrew R Guajardo, Jeffrey M Weinberg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Emerging medical treatments for actinic keratoses, squamous cell carcinoma and basal cell carcinoma
Nasreen Ghuznavi, Nadia F Nocera, Andrew R Guajardo, Jeffrey M Weinberg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Emerging medical treatments for actinic keratoses, squamous cell carcinoma and basal cell carcinoma
Nasreen Ghuznavi, Nadia F Nocera, Andrew R Guajardo, Jeffrey M Weinberg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Emerging medical treatments for actinic keratoses, squamous cell carcinoma and basal cell carcinoma
Nasreen Ghuznavi, Nadia F Nocera, Andrew R Guajardo, Jeffrey M Weinberg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Emerging medical treatments for actinic keratoses, squamous cell carcinoma and basal cell carcinoma
Nasreen Ghuznavi, Nadia F Nocera, Andrew R Guajardo, Jeffrey M Weinberg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Emerging medical treatments for actinic keratoses, squamous cell carcinoma and basal cell carcinoma
Nasreen Ghuznavi, Nadia F Nocera, Andrew R Guajardo, Jeffrey M Weinberg
Review: Clinical Trail Outcomes: Clinical Investigation